Amit Munshi
Amit D. Munshi has served as a member of Arena Pharmaceuticals’ Board of Directors since June 2016, and as President and Chief Executive Officer since May 2016. More...
Dr John Ford
Dr John Ford has more than 18 years of ion channel, drug discovery and development experience. More...
Dr Peter Finan
Dr Peter Finan is Partner at Epidarex Capital and currently serves on the board of Clyde Bioscienes, Caldan Therapeutics, Enterprise Therpeutics and Topas Therapeutics. More...
Bart Dzikowski
Bart Dzikowski is a Managing Director at the Novartis Venture Fund and its Head of Transactions & Legal based in Basel, Switzerland. More...
Dr Alex Mayweg
Alex is a Partner at Versant. Alex is an accomplished leader in pharmaceutical drug discovery and medicinal chemistry across Europe, the U.S. and Asia. More...
Dr Gert-Jan Mulder MD
Geert-Jan co-founded Forbion in 2006 and is currently the Managing Partner. Geert-Jan currently serves on several boards including AM-Pharma, Promedior Inc., Laboratoris Sanifit, NeRRe Therapeutics and KaNDy Therapeutics. More...
Craig Richardson
Craig is a Partner in IP Group’s Life Science investment team. He started his career in the pharmaceutical industry in 1998 and worked in new product development for Glaxo Wellcome More...
